Compare MLGO & EDSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MLGO | EDSA |
|---|---|---|
| Founded | 2018 | 2015 |
| Country | China | Canada |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 49.9M | 51.6M |
| IPO Year | 2020 | 2018 |
| Metric | MLGO | EDSA |
|---|---|---|
| Price | $4.10 | $5.41 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $5.00 |
| AVG Volume (30 Days) | 29.1K | ★ 51.2K |
| Earning Date | 04-01-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $87,132,230.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $0.91 | ★ N/A |
| Revenue Growth | ★ 6.21 | N/A |
| 52 Week Low | $3.02 | $0.72 |
| 52 Week High | $13.60 | $20.32 |
| Indicator | MLGO | EDSA |
|---|---|---|
| Relative Strength Index (RSI) | 46.69 | 43.28 |
| Support Level | $3.95 | $4.80 |
| Resistance Level | $4.44 | $5.82 |
| Average True Range (ATR) | 0.17 | 0.54 |
| MACD | 0.02 | 0.09 |
| Stochastic Oscillator | 28.40 | 68.32 |
MicroAlgo Inc is engaged in the development and application of bespoke central processing algorithms and provides solutions by integrating these algorithms with software or hardware, or both, to streamline digital services. Its services include algorithm optimization, accelerating computing power without hardware upgrades, lightweight data processing, and data intelligence services. Its technology and solutions are mainly in internet multimedia video advertising, where it provides advertising distribution solutions, software services, comprehensive solutions for enterprise customers, and intelligent chips solutions. It derives revenue from central processing algorithm services for internet advertisement and intelligent chips and services, with maximum revenue generated from Mainland PRC.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.